JPS5210877B2 - - Google Patents

Info

Publication number
JPS5210877B2
JPS5210877B2 JP47111219A JP11121972A JPS5210877B2 JP S5210877 B2 JPS5210877 B2 JP S5210877B2 JP 47111219 A JP47111219 A JP 47111219A JP 11121972 A JP11121972 A JP 11121972A JP S5210877 B2 JPS5210877 B2 JP S5210877B2
Authority
JP
Japan
Prior art keywords
novel compounds
alkoxy
pharmaceutical
convulsant
styryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP47111219A
Other languages
English (en)
Japanese (ja)
Other versions
JPS49132088A (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP47111219A priority Critical patent/JPS5210877B2/ja
Application filed filed Critical
Priority claimed from JP11229173A external-priority patent/JPS5224032B2/ja
Priority to JP48112289A priority patent/JPS5224031B2/ja
Priority claimed from JP11229073A external-priority patent/JPS5246235B2/ja
Priority to DE19732355420 priority patent/DE2355420A1/de
Priority to FR7340568A priority patent/FR2205515B1/fr
Priority to BE137507A priority patent/BE807031A/xx
Priority to ES420389A priority patent/ES420389A1/es
Priority to CA189,574A priority patent/CA1055492A/en
Priority to GB58874A priority patent/GB1416412A/en
Priority to SE7400215A priority patent/SE398502B/xx
Priority to NL7400278A priority patent/NL7400278A/xx
Priority to AT13574*#A priority patent/AT333287B/de
Priority to CH191374A priority patent/CH591465A5/xx
Publication of JPS49132088A publication Critical patent/JPS49132088A/ja
Publication of JPS5210877B2 publication Critical patent/JPS5210877B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
JP47111219A 1972-11-08 1972-11-08 Expired JPS5210877B2 (no)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP47111219A JPS5210877B2 (no) 1972-11-08 1972-11-08
JP48112289A JPS5224031B2 (no) 1972-11-08 1973-10-08
DE19732355420 DE2355420A1 (de) 1972-11-08 1973-11-06 Neue piperazin-oder homopiperazinmonoalkanolester und verfahren zu ihrer herstellung
FR7340568A FR2205515B1 (no) 1972-11-08 1973-11-07
BE137507A BE807031A (fr) 1972-11-08 1973-11-07 Nouveaux piperazine- ou homopiperazine monoalkanol-esters et leur procede de preparation
ES420389A ES420389A1 (es) 1972-11-08 1973-11-08 Un procedimiento para la produccion de un nuevo ester pipe-razinu homopiperazin-monoalcanolico.
GB58874A GB1416412A (en) 1972-11-08 1974-01-07 Piperazinyl-and monopiperazinyl monoalkanol esters and a process of production thereof
CA189,574A CA1055492A (en) 1972-11-08 1974-01-07 Piperazine-and homopiperazine-monoalkanol esters and a process of production thereof
SE7400215A SE398502B (sv) 1972-11-08 1974-01-08 Forfarande for framstellning av piperazin- och homopiperazinpropanolestrar med terapeutisk verkan
NL7400278A NL7400278A (nl) 1972-11-08 1974-01-09 Werkwijze voor het in therapeutisch geschikte eningsvorm brengen van nieuwe piper- - of homopiperazinemonoalkanolesters, al- erkregen vormstukken en werkwijze voor het den van deze verbindingen.
AT13574*#A AT333287B (de) 1972-11-08 1974-01-09 Verfahren zur herstellung von neuen piperazin- oder homopiperazinmonoalkanolestern
CH191374A CH591465A5 (no) 1972-11-08 1974-02-12

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP47111219A JPS5210877B2 (no) 1972-11-08 1972-11-08
JP48112289A JPS5224031B2 (no) 1972-11-08 1973-10-08
JP11229173A JPS5224032B2 (no) 1973-10-08 1973-10-08
JP11229073A JPS5246235B2 (no) 1973-10-08 1973-10-08

Publications (2)

Publication Number Publication Date
JPS49132088A JPS49132088A (no) 1974-12-18
JPS5210877B2 true JPS5210877B2 (no) 1977-03-26

Family

ID=27469891

Family Applications (2)

Application Number Title Priority Date Filing Date
JP47111219A Expired JPS5210877B2 (no) 1972-11-08 1972-11-08
JP48112289A Expired JPS5224031B2 (no) 1972-11-08 1973-10-08

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP48112289A Expired JPS5224031B2 (no) 1972-11-08 1973-10-08

Country Status (10)

Country Link
JP (2) JPS5210877B2 (no)
AT (1) AT333287B (no)
BE (1) BE807031A (no)
CA (1) CA1055492A (no)
CH (1) CH591465A5 (no)
DE (1) DE2355420A1 (no)
FR (1) FR2205515B1 (no)
GB (1) GB1416412A (no)
NL (1) NL7400278A (no)
SE (1) SE398502B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173380B (hu) * 1977-02-25 1979-04-28 Richter Gedeon Vegyeszet Sposob poluchenija novogo proizvodnogo piridil-piperazina i kislo-additivnykh solejj
JPS53144591A (en) * 1977-05-20 1978-12-15 Asutaabueruke Ag Chem Fuaburii Process for preparing homopirerazine
DE3403778A1 (de) * 1984-02-03 1985-08-08 Degussa Ag, 6000 Frankfurt Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2088019A1 (en) * 1970-05-08 1972-01-07 Rabot Ets David Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
FR2088018A1 (en) * 1970-05-03 1972-01-07 Rabot Ets David Vasodilatory, substd nicotinic acid amino ester derivs
FR2134121A1 (en) * 1971-04-20 1972-12-08 Penciolelli Madeleine Piperazino ethyl phloroglucates prepn - useful as vasodilators

Also Published As

Publication number Publication date
ATA13574A (de) 1976-03-15
CH591465A5 (no) 1977-09-15
JPS5224031B2 (no) 1977-06-28
JPS49132088A (no) 1974-12-18
NL7400278A (nl) 1975-04-10
GB1416412A (en) 1975-12-03
DE2355420A1 (de) 1974-07-04
SE398502B (sv) 1977-12-27
FR2205515A1 (no) 1974-05-31
BE807031A (fr) 1974-03-01
CA1055492A (en) 1979-05-29
AT333287B (de) 1976-11-10
FR2205515B1 (no) 1978-11-17
JPS5062983A (no) 1975-05-29
SE7400215L (no) 1975-04-16

Similar Documents

Publication Publication Date Title
GB1223690A (en) Substituted chromon-2-carboxylic acids
IE36947B1 (en) New esters their production and their medicinal use
GB1218591A (en) Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation
GB1380225A (en) Biphenylyl- alkanoylaminopyridines and acid addition salts thereof
ES8305366A1 (es) "procedimiento para la preparacion de derivados de penem".
GB1531963A (en) Pyrido(1,2alpha)pyrimidine derivatives
FR2205515B1 (no)
IE44339L (en) Piperazine derivatives.
GB1260352A (en) New derivatives of benzoxazolin-2-one and methods for producing the same
GB1361863A (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB1299201A (en) Medicaments derived from thiazolidine carboxylic acid
GB1426200A (en) Nahpthyridine derivatives
GB1266780A (no)
GB1244481A (en) Benzothiazine derivatives and the preparation thereof
GB1327536A (en) Xanthen-2-yl-propionic acids
GB1437149A (en) Spiro-compounds and a process for their preparation
GB1187071A (en) N-Amino-Substituted 4-Anilino-Pyridines
FR2361896A1 (fr) Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament
GB1384523A (en) Oxime derivatives and their preparation
GB1472937A (en) Benzyl alcohol derivatives
GB1259400A (no)
GB1527941A (en) 1-(3-phenylpropyl)-4-(beta-alkoxyacryloyl)piperazine derivatives
GB1188499A (en) Method for the preparation of Basic Derivatives of Xanthone
IE35783L (en) Molecular complexes
GB1410852A (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them